ETFELA (N-ethyl-N-(2,2,2-trifluoroethyl)lysergamide) is an analogoflysergic acid diethylamide (LSD) first synthesised by Jason C. Parrish as part of the research team led by David E. Nichols. In studies in vitro, it was found to be slightly more potent than LSD itself.[1][2]
Clinical data | |
---|---|
Other names | LA-CH2CF3 |
Identifiers | |
| |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H22F3N3O |
Molar mass | 377.411 g·mol−1 |
3D model (JSmol) | |
| |
|
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |